Rob Van Manen

Rob Van Manen

Oracle Corporation - Redwood City / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4615518
-
person_outline Rob Van Manen's MOST POPULAR ARTICLES
1-) Dipeptidyl peptidase-4 inhibitor–associated pancreatic carcinoma: a review of the FAERS databaseAK Nagel, N Ahmed-Sarwar, PM Werner, GC Cipriano, RP Van Manen, ...Annals of Pharmacotherapy 50 (1), 27-31, 2016292016
2-) Signal detection methodologies to support effective safety managementRP van Manen, D Fram, W DuMouchelExpert Opinion on Drug Safety 6 (4), 451-464, 2007322007
3-) Tigecycline‐related pancreatitis: a review of spontaneous adverse event reportsE Okon, C Engell, R van Manen, J BrownPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 33 (1 …, 2013312013
4-) Lysosomal activity in the aging rat liver: II. Morphometry of acid phosphatase positive dense bodiesW De Priester, R Van Manen, DL KnookMechanisms of ageing and development 26 (2-3), 205-216, 1984301984
5-) Lysosomal activity in aging rat liver: I. Variation in enzyme activity within the liver lobuleR Van Manen, W De Priester, DL KnookMechanisms of ageing and development 22 (2), 159-165, 1983201983